Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 01-Nov-2022 titled Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility – Final Approval for Glycopyrrolate……
Subscribe To Our Free Newsletter |